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Abstract
Introduction: Nodding Syndrome (NS), an unexplained illness characterized by spells of head bobbing, has been reported in
Sudan and Tanzania, perhaps as early as 1962. Hypothesized causes include sorghum consumption, measles, and
onchocerciasis infection. In 2009, a couple thousand cases were reportedly in Northern Uganda.
Methods: In December 2009, we identified cases in Kitgum District. The case definition included persons who were
previously developmentally normal who had nodding. Cases, further defined as 5- to 15-years-old with an additional
neurological deficit, were matched to village controls to assess risk factors and test biological specimens. Logistic regression
models were used to evaluate associations.
Results: Surveillance identified 224 cases; most (95%) were 5–15-years-old (range = 2–27). Cases were reported in Uganda
since 1997. The overall prevalence was 12 cases per 1,000 (range by parish = 0?6–46). The case-control investigation (n = 49
case/village control pairs) showed no association between NS and previously reported measles; sorghum was consumed by
most subjects. Positive onchocerciasis serology [age-adjusted odds ratio (AOR1) = 14?4 (2?7, 78?3)], exposure to munitions
[AOR1 = 13?9 (1?4, 135?3)], and consumption of crushed roots [AOR1 = 5?4 (1?3, 22?1)] were more likely in cases. Vitamin B6
deficiency was present in the majority of cases (84%) and controls (75%).
Conclusion: NS appears to be increasing in Uganda since 2000 with 2009 parish prevalence as high as 46 cases per 1,000 5-
to 15-year old children. Our results found no supporting evidence for many proposed NS risk factors, revealed association
with onchocerciasis, which for the first time was examined with serologic testing, and raised nutritional deficiencies and
toxic exposures as possible etiologies.
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Introduction
An unusual syndrome referred to as ‘‘nodding disease’’ or
‘‘nodding syndrome’’ (NS) due to characteristic spells of repetitive
head bobbing has been reported among populations in Africa,
perhaps as early as 1962 in Tanzania. [1] The syndrome is
characterized by stereotypic head nodding, along with variable
other features including apparent seizures, cognitive and physical
impairment, and progressive functional difficulties, with onset
during childhood. In the late 1900s, ‘‘rhythmic dorsoventral head
movements’’ in Liberia [2,3] and ‘‘repetitive head movements’’ in
Western Uganda [4] were noted to resemble the same ‘‘head
nodding’’ though they may not represent one distinct seizure type.
More recently, the syndrome termed NS has been investigated
among internally displaced people in southern Sudan in 2001–02
[5,6] and among children in the Mahenge region in Tanzania in
2005. [7,8].
The underlying cause, natural history and pathophysiology
remain unclear despite prior investigations. The primary feature of
NS is a paroxysmal ‘‘spell’’ in which the head bobs forward
repeatedly over a period of minutes; nodding is often reported to
happen at the sight of food, with cold temperatures, and ‘‘when
the moon appears.’’ In most cases the child appears unresponsive
during the episode. Children with NS have variably been
described to develop other physical and neurological signs,
primarily growth stunting, and cognitive regression. [5,8] The
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nodding episodes are thought to be the sentinel feature of a more
progressive neurological illness, in which there is neurological
deterioration including progressive seizures. [5,8] Electroenceph-
alography (EEG) results from a prior study suggest that at least a
subset of children with head nodding have other types of clinical
and subclinical seizures. [7] Studies, including brain magnetic
resonance imaging and cerebrospinal fluid (CSF) analysis, have
not suggested an etiology. [7] Anecdotal reports have described
the natural history of the illness as one of progressive neurologic
deterioration, physical wasting, and ultimately death. In focus
groups, Ugandans report symptoms consistent with the NS
described in other sub-Saharan countries (UgMOH, WHO,
CDC, unpublished report).
Proposed risk factors or causes have included psychogenic
illness, infectious agents, genetic disease, toxins, and nutritional
disorders. Exposures that were found to have significant associ-
ations with NS in Sudan included onchocerciasis, [9] a self-
reported history of measles, and red sorghum grain consumption
(Anker, unpublished report).
In 2009, the Kitgum District Health Office reported to the
Uganda Ministry of Health approximately 2,000 cases suggestive
of NS among persons previously displaced by war. Given the
complex nature of the disease and the range of possible etiologies,
the U.S. Centers for Disease Control and Prevention was asked to
assist the Ministry to investigate and respond to the outbreak. We
conducted a case-control investigation to identify potential risk
factors and etiologies for development of NS, and to direct control
efforts.
Methods
In December 2009, we conducted a multidisciplinary investi-
gation including surveillance, case-control, clinical case-series, and
qualitative assessments in western Kitgum District, Uganda. The
clinical case-series as well as the focus groups which informed
questionnaire development and interpretation of results are
described elsewhere. [10] For surveillance purposes, we defined
a case of NS as a previously developmentally normal person of any
age with nodding episodes where the head drops forward
repeatedly (Table 1). To narrow the definition for the case-control
investigation, a case also was required to have another neurolog-
ical abnormality. Age was limited to 5- to 15-years-old for cases
and controls, the age group in which most children with the
syndrome fell.
Cases were recruited across western Kitgum District through
surveillance that included radio announcements and community
outreach by community leaders and health workers to affected
families and targeted NS populations. Potential cases were
interviewed in-person by surveillance teams using a structured
questionnaire. Only subjects meeting the surveillance case
definition were counted.
For the concurrent case-control investigation, cases (total n = 51)
were matched on location to an unrelated village control who was
not living in the same household as the case (n = 49) and/or to a
sibling in the household (n = 44) who were neurologically normal.
Based upon the results of previous investigations, focus group
interviews of community members (UgMOH, WHO, CDC,
unpublished report), and the input of subject matter experts, we
generated a list of possible risk factors including infectious diseases,
nutritional deficiencies, heavy metals, pesticides, war munitions,
post-traumatic stress, mass hysteria, pseudoseizures, and genetic
disorders.
After informed consent, in-person interviews were conducted in
the native Acholi language through translators with a health
background, by physicians, other health providers, and non-
clinical researchers, to collect exposure information and clinical
findings. Respondents were also asked: where they were living
when the nodding began to assess if location at symptom onset
contributed to NS risk; whether a family member had been
abducted to assess for potential social stressors; and about
occurrence of visual or auditory hallucinations and school
attendance to explore potential disease manifestations in cases.
Additionally, on physical examination we assessed for skin
nodules, a feature characteristic of onchocerciasis. Measurement
of height and weight were obtained using a stadiometer and digital
scale to calculate anthropometric indices including body mass
index (BMI, kg/m2), low BMI-for-age z-score (defined as ,22
standard deviations (SD)), and low height-for-age z-score
(,22SD).
Laboratory specimens collected on all subjects included serum,
whole blood, and urine. Two skin snips were taken from the iliac
crests of all subjects with a 2 mm Holth corneoscleral punch and
microscopically examined after incubation for 30 minutes in
distilled water (and a further 24 hours in saline for negative skin
snips) for the presence and number of O. volvulus microfilariae. [11]
When selecting a subset of cases for CSF testing, we prioritized
cases with a high clinical likelihood of head nodding. Cell counts
were not performed on freshly obtained CSF due to the remote
field location. Specimens were appropriated to various laboratories
for testing: skin snip O. volvulus microfilariae (counted in the field
by Uganda MOH parasitologists); ALT, AST, alkaline phospha-
tase, creatinine, urea, bilirubin (St. Joseph’s Hospital, Kitgum,
Uganda); O. volvulus Ov16, OvFAR/MSA serology (Laboratory of
Parasitic Diseases, U.S. National Institutes of Health); Hepatitis E
Table 1. Case definitions for persons with Nodding Syndrome. Criteria 1–2 were required‘ for surveillance purposes and 1–5* were
required for enrollment in the case-control investigation.
1 The presence of one or more episodes of head nodding. Head nodding was defined as repetitive dropping of the head with periodicity of 10–30 times over
a period of 1 minute or more.
2 A child who was developmentally normal before onset. Developmentally normal was defined as meeting developmental milestones by parental report.
3 Age 5 to 15 years
4 At least one other definitive neurological abnormality, which could be either reported or observed. Definitive neurological abnormalities included loss of
developmental milestones, generalized tonic-clonic seizures, objective neurological exam findings (e.g. spasticity, ataxia), or other clear sign of neurological
deficit.
5 Lack of improvement
‘as determined by Uganda Ministry of Health and WHO epidemiologists.
*as determined by CDC medical epidemiologist.
doi:10.1371/journal.pone.0066419.t001
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serology (Uganda Virus Research Institute); Taenia solium serology
(CDC Parasitic Diseases Branch); Trypanosoma gambiense serology
(Prince Leopold Institute for Tropical Medicine Parasite Diag-
nostics Unit); RBC folate, serum vitamins B6, B12, A (CDC
Nutritional Biomarkers Branch); serum zinc, selenium, copper,
urine mercury (CDC Inorganic and Radiation Analytical Toxi-
cology Branch); urine homocysteine (ARUP commercial national
reference laboratory); urine thiocyanate (CDC Emergency Re-
sponse Branch), serum and CSF multiplex PCR (CDC Gastroen-
teritis and Respiratory Virus Laboratory Branch); CSF protein,
glucose (Children’s Hospital of Atlanta Cytology Laboratory); and
CSF measles PCR (CDC Measles, Mumps, Rubella and Herpes
Virus Laboratory Branch). We focused on testing for exposures
thought to cause CNS disease, hypothesized to be associated with
NS previously, or recognized to have caused epidemics in the
region during the years preceding the rise in NS cases. Tests were
run on all available specimens when possible. Because of resource
limitations, some laboratory tests (vitamin B12, vitamin A, zinc,
selenium, copper, folate, mercury, homocysteine) were run on a
subsample of available specimens selected by using a random digit
table.
Analysis
Prevalence was calculated for each parish visited by dividing the
number of 5- to 15-year-old cases by the number of 5- to 15-year-
olds in each subcounty using 2009 census data. Conditional
logistic regression models were used to estimate the associations
between NS and exposures or clinical findings; unadjusted and
adjusted odds ratios and 95% confidence intervals (CI) were
calculated. Because cases were significantly older than controls in
our sample, all final models were age-adjusted. We examined the
association between each individual exposure and disease, using
three strategies to control for potential covariates. The first
adjusted for age (model 1); the second adjusted for significant
exposures in our investigation including munitions, crushed roots,
age (model 2); and the third adjusted significant variables from
previous studies including history of prior measles, sorghum
consumption, onchocerciasis skin snip positive, plus age (model 3).
We tested for all two-way interactions between munitions, crushed
roots, and age as well as all two-way interactions between measles,
sorghum, onchocerciasis skin snips, and age; Wald chi-square tests
were used to assess the significance of interaction terms. Given the
smaller sample size for most laboratory results, unmatched
multiple logistic regression was used to explore unadjusted and
age-adjusted associations between lab results and case status. SAS
software (version 9?2; SAS Institute) was used for analyses.
Human Subjects
This investigation was reviewed in accordance with CDC
human subjects review procedures and determined to be a non-
research public health response activity by not meeting the
regulatory definition of research under 45 CFR 46.102(d), with
concurrence from the Uganda Ministry of Health. The purpose
and the nature of the investigation were explained to parents/
caregivers, including risks and benefits of each of the procedures
and evaluations; all parents/caregivers provided written informed
consent for their children to be included in the investigation.
Parents/caregivers were free to decline participation. Measures
were maintained to protect patient confidentiality.
Results
We identified 224 persons who met the surveillance case
definition (n= 30 cases unique to the case-control study, n = 173
unique to surveillance, n= 21 in both studies), of whom 95% were
between the ages of 5 and 15 years (range = 2–27) (Figure S1;
available online). Except for a single case with onset reported in
1997, all cases in this northern Ugandan population reported
onset after 2000, and there was a generally higher number of
reported cases annually through 2009 (Figure 1). Analysis of
disease onset by month revealed no evidence of seasonal variation.
The overall prevalence in 13 parishes of western Kitgum District
was 12 (exact 95% CI= 10?8, 14?2) cases per 1000 five- to fifteen-
year-old children, but ranged widely from 0?6 (0, 3?6) to 46 (36?5,
57?7) cases per 1000.
All case-control subjects were formerly internally displaced
people (i.e. previously living in another area of Uganda due to war)
now living in Kitgum district (Table 2). Despite testing controls
within the same age range as cases, cases were significantly older
than controls and later in birth order. All other socio-demographic
characteristics were similar between cases and controls. Most
subjects were cared for by parent(s) who had less than a primary
school education and were unemployed, and had a family member
who had been abducted.
Cases were more likely to report exposure to munitions prior to
disease onset than controls queried for the same time period
(Table 3). Cases also had higher age-adjusted odds of crushed root
consumption. Findings indicated no difference in age-adjusted
odds of sorghum consumption or self-reported history of measles.
Results remained similar with adjusted models 2 and 3 (Table S1;
available online) and no significant interactions were found. For
location at the time of NS onset in the matched case, most cases
and controls were living in Kitgum Town Council (39% and 31%,
respectively), Namokora/Atiak (35%, 29%), or Palabek Gem
(20%, 25%) subcounties. For anthropometric indices, 60% of cases
had low height-for-age as compared to 29% of controls
(p = 0?003). Cases also had higher frequencies of low BMI-for-
age (42%) as compared to controls (13%, p= 0?001). In addition to
the neurological signs included in the case definition, cases were
also more likely to report visual hallucinations and to have
dropped out of school. (Of note, further investigation with
culturally appropriate clinical assessments should be made for
any clinical findings as case-control questioning is appropriate for
uncovering reported differences from a control population but
should not serve as the primary information on which to base these
clinical care decisions.) Additional clinical findings from the case-
series investigation, including details on the gross cognitive
impairment in cases and atonic seizures causing nodding, are
presented separately. [10].
Laboratory results demonstrated no significant difference
between cases and controls for most variables (Table 4). However,
cases were more likely than controls to have O. volvulus-specific IgG
antibodies by both serologic assays. Also, most cases and controls
had low vitamin B6 levels, as measured by serum pyridoxal-59-
phosphate (PLP) [12]. We explored whether the co-occurrence of
the two exposures, positive onchocerciasis and low serum PLP,
were associated with case status, however there was no evidence of
a significant interaction between the two.
Results of analyses comparing cases to household controls or to
all controls found no additional associations.
Discussion
We provide evidence for a recent epidemic of NS in Kitgum
district localized geographically to northern Uganda. Similar to
reports from Tanzania [7] and Sudan [13], the age distribution of
the affected population is clustered tightly among the 5–15 year
old age group. Our findings on risk factors provide additional data
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supporting the association of onchocerciasis with NS, but did not
support other previous hypotheses. Additionally, new associations
emerged including exposure to munitions and consumption of
crushed roots; and both cases and controls were found to have an
unusual micronutrient profile.
We found the number of children with reported NS onset to be
higher in more recent years. This suggests that the number of NS
Figure 1. Epidemic curve depicting time course of disease onset: cases identified by surveillence and case-control studies in Kitgum
District plotted by reported NS onset year.*.
doi:10.1371/journal.pone.0066419.g001
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cases may be increasing in Kitgum district since 2002. Alternate
reasons, such as moving away or death, could potentially explain
why onset was less frequent in earlier years though this was not
substantiated in qualitative interviews done as part of this
investigation.
We identified munitions and crushed roots as significant risk
factors that have not been assessed in prior investigations. We
hypothesized that munitions exposure might indicate potential
chemical exposure. However, no known exposures of this type
were revealed in focus groups countries (UgMOH, WHO, CDC,
unpublished report) or in open-ended questionnaire responses of
this case-control study. Instead some respondents indicated the
exposure was to guns during raids. Since the munitions association
also had a wide confidence interval, the importance of this finding
is unclear and warrants further investigation.
Crushed roots were consumed as traditional medicines at higher
rates among cases than controls. We were concerned that cassava
roots might have caused neurotoxicity but testing for urinary
thiocyanates, one indicator of cyanide toxicity from cassava
consumption, provided no evidence for ongoing toxicity. Although
the roots may have contributed to the development of NS, it is also
possible that some respondents confused the question specifying
exposures prior to NS onset with medicines given to treat the
disease. This distinction, along with type of crushed root, mode of
administration and reason for use should be explored in future
studies. Community elders report that numerous traditional
medicines are used in the region, made from a variety of roots,
stems, bark, and leaves, to treat various maladies including
epilepsy (Odonga, unpublished communication).
Contrary to previous findings of a 2001 South Sudan
investigation (Anker, unpublished report), our case-control inves-
tigation suggests that there is no significant association between NS
and a history of measles, a risk factor of interest due to the
association of measles with subacute sclerosing panencephalitis, a
progressive neurologic complication of an aberrant measles virus
infection. In fact, measles by history was less common among cases
in the previous study, and slightly more common in ours.
Our investigation adds additional information on the previously
identified association between NS and onchocerciasis with the
most extensive analyses of the association to date. While other
investigations have assessed for an association between onchocer-
ciasis and NS, [7,9] our investigation provided additional
laboratory testing of the cases, and included comparisons with
two groups of controls using robust statistical analyses. This
association was particularly strong for antibodies measured in the
more sensitive OvFAR/MSA LIPS assay, which was positive in
95% of cases. [14] Though the presence of O. volvulus microfilariae
by skin snip was more common among cases, it was not
significantly so. Skin snip testing indicates presence of viable
parasites in the skin and may be transient or affected by treatment,
while anti-O. volvulus IgG antibodies remain present indefinitely,
and are a more sensitive indicator for exposure to onchocerciasis.
The association between case status and onchocerciasis is
puzzling. Though extensive previous literature debates the
relationship between onchocerciasis and epilepsy [15–17], the
biological mechanism by which O. volvulus might cause epilepsy or
NS is not clear. O. volvulus is typically associated with eye disease by
triggering the host immune system leading to ocular tissue
destruction. [18] O. volvulus is not known to cause invasive
infection of the central nervous system. Moreover, there has been
no laboratory evidence of the parasite in the brain or CSF as signs
of CSF inflammation has been generally absent in NS cases,
Table 2. Prevalence and mean socio-demographic characteristics of nodding syndrome case patients and control subjects aged 5
to 15 years in Kitgum District, Uganda.
Characteristic Cases Village Controls Household Controls
Total subjects 51‘ 49 44
Male gender 55% 44% 45%
Age
Mean 11?6 years 8?5 years** 8?1 years**
Birth Order
Mean 4?1 3?2* 4?9**
Range 1–9 1–10 1–10
Parent caretaker 86% 84% 86%
Family member abducted 59% 49% 57%
Father’s education
None 10% 17% 8%
,Primary school 57% 46% 55%
Graduated primary school or above 33% 37% 37%
Mother’s education
None 34% 43% 42%
,Primary school 58% 45% 51%
Graduated primary school or above 8% 13% 7%
Primary caretaker is employed 6% 6% 5%
‘51 total cases were enrolled; 49 matched to 49 village controls, and 44 matched to 44 household controls.
McNemar’s, Stuart’s [27], and paired t tests were performed to obtain significance level.
*p,0.05.
**p,0.001.
doi:10.1371/journal.pone.0066419.t002
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Table 3. Frequency of nodding syndrome cases and village controls with positive exposures or presence of clinical findings.
Positive Cases %* Positive Controls % OR` (95%CI) AOR Model 1{ (95%CI)
Exposure
Ever treated for Onchocerciasis 33?3 24?5 1?7 (0?6, 4?6) 1?1 (0?3, 3?8)
Family member abducted 58?8 49?0 1?5 (0?6, 3?7) 1?0 (0?3, 2?9)
History of
Measles 23?5 6?1 4?0 (1?1, 14?2) 3?3 (0?8, 13?6)
Malaria‘ 43?1 59?2 0?5 (0?2, 1?2) 0?7 (0?2, 1?9)
Malnutrition‘ 3?9 4?1 0?6 (0?1, 2?7) 1?0 (0?2, 4?8)
Pneumonia‘ 0?0 2?0 0?4 (0?0, 16?5)+ 0?6 (0?0, 35?1)+
Diarrhea‘ 2?0 4?1 0?7 (0?2, 3?4) 0?7 (0?1, 3?7)
Head injury‘ 2?0 0?0 0?4 (0?0, 3?3)+ 0?2 (0?0, 1?8)+
Tapeworm 0?0 0?0 – –
Consumption of
Red sorghum 98?0 100 0?2 (0?0, 15?4)+ 1?3 (0?0, 125?9)+
Spoiled relief foods 43?1 46?9 0?7 (0?2, 2?3) 0?3 (0?1, 1?3)
Supplementary foods 21?6 12?2 1?8 (0?6, 5?4) 1?5 (0?4, 5?5)
Seeds meant for planting 60?8 65?3 0?9 (0?3, 2?6) 0?6 (0?1, 2?3)
River Fish 96?1 100 0?3 (0?0, 11?6)+ 0?3 (0?0, 11?6)+
Insects 41?2 32?7 1?5 (0?5, 4?2) 0?8 (0?2, 2?9)
Rodent brain 54?9 51?0 2?0 (0?4, 10?9) 1?8 (0?3, 12?3)
Guinea fowl brain 7?8 4?1 2?5 (0?5, 12?9) 2?4 (0?4, 14?8)
Bush meat 100 100 – –
Cassava 100 100 – –
Use of traditional or herbal medicines
Crushed roots‘ 39?2 16?3 5?0 (1?4, 17?3) 5?4 (1?3, 22?1)
Crushed leaves‘ 7?8 2?0 4?0 (0?4, 35?8) 3?4 (0?2, 45?8)
Crushed flowers‘ 0?0 2?0 0?7 (0?1, 4?3) 0?9 (0?1, 5?6)
Inhaled medicine‘ 2?0 0?0 0?3 (0?0, 3?0)+ 0?2 (0?0, 1?5)+
Lotion 0?0 0?0 – –
Broth 0?0 0?0 – –
Water source for domestic use
Rivers/streams 80?7 83?7 0?1 (0?0, 5?2)+ 0?1 (0?0, 3?6)+
Boreholes 96?1 100 0?1 (0?0, 4?1)+ 0?3 (0?0, 14?5)+
Shallow wells 11?8 6?1 4?0 (0?4, 35?8) 3?4 (0?2, 45?8)
Springs 5?9 4?1 1?5 (0?3, 9?0) 2?6 (0?3, 21?4)
Piped water 0?0 0?0 – –
Exposure to
Munitions 70?6 51?0 10?0 (1?3, 78?1) 13?9 (1?4, 135?3)
Unusual illness/death of animals 52?9 53?1 0?6 (0?2, 1?9) 0?6 (0?1, 2?3)
Swimming in the river‘ 17?7 22?5 0?7 (0?2, 2?4) 0?3 (0?1, 1?7)
Swimming in the pond‘ 7?8 4?1 3?0 (0?3, 28?8) 1?9 (0?1, 36?0)
Clinical Finding
Physical examination
Skin Nodules‘ 7?8 8?2 1?0 (0?3, 4?0) 0?5 (0?1, 2?6)
Low height for age‘, ** 60?0 29?2 3?6 (1?3, 9?7) 2?5 (0?8, 7?7)
Low BMI for age‘, ** 42?2 12?5 4?0 (1?3, 12?0) 2?0 (0?5, 7?4)
Clinical characteristic
Visual Hallucinations‘ 29?4 4?1 14?0 (1?8, 106?5) 13?6 (1?5, 121?7)
Auditory Hallucinations‘ 25?5 0 44?9 (2?3, 858?3)+ 14?9 (0?7, 299?1)+
School Attendance 52?9 85?7 0?2 (0?1, 0?6) 0?1 (0?0, 0?6)
Risk Factors for Nodding Syndrome
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[-
7,10,16] and Tanzania and South Sudan investigations failed to
find evidence of O. volvulus by spinal fluid PCR. [6,7] Also, though
all known cases of NS have occurred in onchocerciasis areas,
onchocerciasis is endemic in many parts of the world and NS has
only been described in limited geographic areas. It is possible that
a new antigenic form of O. volvulus is present in areas with NS;
however, at present there are no data to support this. Additionally,
we wondered if children with NS had treatment for onchocerciasis
withheld based on the presence of neurologic illness. However no
difference was found in reported receipt of treatment between
cases and controls (Table 3). Also, it is possible that additional risk
factor(s) need to be present to result in NS. Lastly, we cannot
determine whether higher levels of anti-onchocerca antibodies
present in cases occurred before or after NS onset. In focus groups
(UgMOH, WHO, CDC, unpublished report), informants reported
that children with NS were less able to swat away black flies given
their functionally impaired condition and thus may have been
more likely to be bitten by vectors carrying the onchocerca
parasite. Alternatively, onchocerciasis may be an indicator of
another exposure that is the actual cause of NS.
Cases were malnourished, with 60% having a low height-for-
age, and 42% having a low BMI. Exposure questions aimed at
assessing nutritional status prior to NS onset, including reported
history of malnutrition or consumption of supplementary foods,
revealed no difference between cases and controls. In addition, we
assessed nutritional biomarker and heavy metal levels, hypothe-
sizing that there may be a role for nutritional deficiencies or
intoxications in the development of NS. All cases and controls had
low selenium which is likely a reflection of the poor diet quality in
this population. Additionally, we found the majority of subjects
having low PLP levels. Though both cases and controls have high
levels of apparent vitamin B6 deficiency, the findings do raise the
question as to whether low vitamin B6 could contribute to disease
pathogenesis. Vitamin B6 is important for neurotransmitter
synthesis, and depletion can impair neurologic function and result
in intractable seizures.[19–21] In a controlled depletion-repletion
study, [22] 2 of 11 young women placed on a low vitamin B6 diet
(,0?05 mg of pyridoxine) exhibited abnormal EEG patterns when
plasma PLP levels dropped to about 9 nmol/L. In addition,
pyridoxine-dependent seizures, a rare form of early childhood
epilepsy, is refractory to usual anti-epileptic medications but can
be successfully treated with high doses of pyridoxine. [23].
A number of variables might help explain the unusual nutrition
profile with low serum PLP levels, though such an isolated vitamin
deficiency is uncommon. Field collection, processing and shipping
conditions are unlikely to cause surreptitious low PLP with normal
levels of other B vitamin status indicators. A diet limited to un-
enriched grains increases the risk for developing pyridoxine
deficiency. The Acholi people are agro-pastoralists who relied
primarily on relief food while displaced, and were tapered off of
relief food as they were resettled. A national food consumption
survey in 2008 found that this region of Uganda was unique in
inadequate intakes of vitamin B6 containing foods. [24] Because it
would be expected that other micronutrients would also be low
with low intake of vitamin B6 foods, it is unusual that vitamin B6 is
lower than other micronutrients. Certain substances may lower
PLP levels, including various drugs (isonazid, cycloserine, penicil-
lamine, hydralazine), smoking, excessive alcohol intake, and
consumption of the mushrooms Agaricus bisporis and Gyromitra
esculenta. [25] Additionally, reference values for PLP are not
established for this population of children in Sub-Saharan Africa.
Finally, it is possible that low levels could be related to a high
parasite load. In a model of infection with the filarial parasite
Litomosoides carinii using rodents, rat microfilariae require vitamin
B6 from the host and compete with host cells for vitamin B6; high
microfilariae counts correlate with low pyridoxine. [26] However,
we were unable to document a significant interaction between
onchocerciasis and vitamin B6 deficiency.
A limitation of this investigation is surveillance may under-
estimate (e.g. if cases were missed) true prevalence. Also, because
the critical period where exposure increases risk of developing
nodding is unknown and could be any time from conception to NS
onset, our findings may be unable to discern an effect of NS from a
potential cause of it. Finally, because we examined multiple
associations, some of the associations that we observed may be
false positives, however this investigation was intended to be
exploratory, with a focus on potential public health interventions,
and therefore our findings need to be replicated and expanded in
future studies. Despite these limitations, this investigation adds
new information to the few small, uncontrolled, or unpublished
studies of NS to date.
Conclusions
We identified O. volvulus infection, exposure to munitions, and
crushed roots as potential risk factors for nodding syndrome.
Consumption of red sorghum, river fish, bush meat, and cassava,
drinking water from boreholes, and low selenium levels were found
in nearly all cases and controls; low vitamin B6 was also prevalent
in most subjects. Future studies should explore additional risk
factors within this population and across affected populations, and
better evaluate for a combination of exposures as a potential cause.
Additionally, expanded surveillance should better describe the
prevalence and geographic distribution. While additional investi-
gations are underway to further elucidate the etiology and best
treatment regimens, it is important to ensure that mass onchocer-
ciasis treatment campaigns reach populations with high docu-
Statistically significant values are in bold.
CI: Confidence interval. OR: odds ratio.
*Percent with exposure is calculated by number of cases with a positive exposure divided by number of cases, or number of controls exposed divided by number of
controls.
`Odds ratio calculated as odds of positive exposure in cases versus odds of exposure in controls.
{AOR1: Odds ratio adjusted for age. Note: additional models 2 (adjusted for age, munitions, roots) and 3 (adjusted for age, measles, sorghum, onchocerciasis skin snip
positive) are available in an online appendix Table 5.
ˆMissing data existed for the following exposure variables: malaria, malnutrition, pneumonia, diarrhea, head injury, crushed leaves, roots, flowers, inhaled medicine
(number of cases responding to question = 50); swimming in the river or pond, visual or auditory hallucinations (cases = 49); skin nodules (cases = 48); low height for age,
low BMI for age (cases = 45, controls = 48); all data used for frequencies, data from available matched pairs used for matched analyses.
+Firth’s correction.
**low BMI-for-age z-score: ,22 SD, an indicator of acute malnutrition; low height-for-age z-score: ,22SD, chronic malnutrition.
Unadjusted and adjusted odds of positive exposure or clinical finding in a case versus control.
doi:10.1371/journal.pone.0066419.t003
Table 3. Cont.
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Table 4. Comparison of laboratory findings among nodding syndrome cases and village controls, frequency for positive results or
high value unless otherwise denoted by ‘‘*’’, unmatched unadjusted and age-adjusted odds of an abnormal laboratory value‘, {, "
in a case.
Cases Controls OR AOR**
n % n % (95%CI) (95%CI)
Skin snip
Onchocerca volvulus microfilariae{{{ 45 71?1 39 53?9 2?11 (0?86, 5?2) 1?11 (0?37, 3?27)
Serum
O? volvulus antibody Ov16 by ELISA""" 39 66?7 44 31?8 4?29 (1?71, 10?75) 3?14 (1?08, 9?13)
O? volvulus antibodies OvFAR/MSA by LIPS‘‘ """ 39 94?9 41 48?8 19?42 (4?13, 91?43) 14?40 (2?65, 78?31)
Hepatitis E IgM 38 31?6 31 16?1 2?31 (0?71, 7?50) 1?45 (0?37, 5?68)
Hepatitis E IgG 38 26?3 30 33?3 0?71 (0?25, 2?04) 0?81 (0?24, 2?75)
Hepatitis E IgM/G 38 47?4 31 41?9 1?18 (0?45, 3?08) 1?03 (0?33, 3?21)
Taenia soleum (cystercercosis) antibody 36 0 40 0 – –
Trypanosoma gambiense antibody by CATT{{ 36 0 40 0 – –
Pyridoxal-59-phosphate (vitamin B6)* by HPLC""
fluorometric detection
41 73?2 42 64?3 1?52 (0?59, 3?86) 1?22 (0?41, 3?59)
Cobalamin (vitamin B12)* by immunoassay 25 8?0 12 8?3 0?96 (0?08, 11?72) 1?46 (0?09, 22?82)
Retinol (vitamin A)* by HPLC-UV/VIS*** 25 40?0 12 33?3 1?33 (0?32, 5?64) 2?15 (0?41, 11?12)
Zinc* 17 47?1 12 66?7 0?44 (0?10, 2?06) 0?72 (0?13, 3?94)
Selenium* 17 100 12 100 – –
Copper* 17 0 12 0 – –
Alanine transaminase (ALT) 44 11?4 42 7?1% 1?67 (0?37, 7?46) 1?96 (0?34, 11?40)
Aspartate aminotransferase (AST) 44 59?1 42 64?3 0?80 (0?34, 1?92) 1?23 (0?41, 3?67)
Alkaline phosphatase 44 22?7 42 14?3% 1?77 (0?58, 5?38) 1?28 (0?35, 4?67)
Creatinine* 44 75?0 42 71?4% 1?20 (0?46, 3?12) 2?76 (0?83, 9?20)
Urea* 44 15?9 42 4?8 3?78 (0?74, 19?39) 3?70 (0?60, 22?86)
Total Bilirubin 44 0 42 0 – –
Multiplex PCR‘‘‘ 42 0 0 – – –
Whole blood
Malaria thin and thick smears 22 2?3 21 4?7 0?45 (0?04, 5?40) 0?35 (0?01, 11?72)
Hemoglobin* 43 48?8 39 69?2 0?42 (0?17, 1?05) 0?76 (0?25, 2?31)
RBC Folate* by microbiological assay 11 9?1 9 0 – –
Urine
Mercury 12 0 10 0 – –
Thiocyanate 41 7?3 43 7?0 – –
Homocysteine by spectrophotometry 23 0 9 0 – –
Cerebrospinal fluid
Protein 14 0 0 – – –
Glucose 14 7?1 0 – – –
Measles PCR 16 0 0 – – –
Multiplex PCR‘‘‘ 16 0 0 – – –
*indicates values that where ‘‘low’’ or below normal cut off values and signifies an abnormal test result.
‘Cut off values for positive infectious disease results: onchocerciasis skin snip.0, onchocerciasis Ov16 ELISA .0?1, onchocerciasis OvFAR/2MSA LIPS .7000
(negative,5000) cysticercosis .0, trypanosomiasis .0, hepatitis E .0?22 (Hep E IgM/G was considered reactive if either IgM or IgG was .0?22), measles PCR .0.
{Low values for nutrition results: vitamin B6,20 nmol/L, B12,200 pg/mL, A ,20 mg/dL, Hb 12 g/dL, folate ,317 nmol/L.
"Normal reference ranges: ALT 5?3–43?3 U/l, AST 0–37 U/l, ALP 98–279 U/L, CREA 0?5–1?2 mg/dl, UREA 10–50 mg/dl, TBIL 0–1 mg/dl, copper 60–249 mg/dL, selenium
113–130 mg/L, zinc 70–120 mg/dL, mercury 0?42–3?19 mg/L, thiocyanate ,2100 ng/ml (zero cases and controls had toxic levels .14000 ng/ml); CSF protein 15–45 mg/
dL; CSF glucose 40–70 gm/dL.
**AOR: Odds ratio adjusted for age.
‘‘LIPS – Luciferase immunoprecipitation system.
{{CATT – Card Agglutination Test with Stained Trypanosomes.
""HPLC – High-performance liquid chromatography.
***HPLC-UV/VIS – HPLC method with ultraviolet-visible spectrophotometry detection.
‘‘‘Multiplex PCR tests for 35 groups of family, subfamily or genus nucleic acid targets, covering 19 families of viruses.
{{{Case mf density mean= 39?1 (range 0–204); control mf density = 5?8 (range 0–60).
"""Matched unadjusted and age-adjusted odds were also performed on labs found to have significant associations: O. volvulus Ov16 OR=3.33 (1.34, 8.30) and
AOR= 3.16 (0.84, 11.89), O. volvulus OvFAR/2MSA OR= 17.00 (2.26, 127.74) and AOR=20.80 (1.37, 316.24).
doi:10.1371/journal.pone.0066419.t004
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mented rates of infection and that those with known epilepsy and
micronutrient deficiencies receive appropriate treatment.
Supporting Information
Figure S1 Graphical depiction of age distribution: number of
nodding syndrome cases indentified by surveillance and case-
control studies in Kitgum District by age in years.*
(TIF)
Table S1 Frequency of nodding syndrome cases and village
controls with positive exposures. Adjusted odds of positive
exposure in a case versus control.
(DOCX)
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